Radiolabeling of Zonisamide for a Diagnostic Perspective.

Published in: Current radiopharmaceuticals (2023)

This study showed that the current radiolabeled antiepileptic drug has a diagnostic potential to be used in imaging neurological processes.

Keyphrases